Potential risk of a common hereditary thrombophilia and adjuvant chemotherapy for low-stage breast cancer.
Ely
Susan F
SF
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects; D017809:Fatal Outcome; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006710:Homocysteine / Q000097:blood / Q000235:genetics; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D009154:Mutation; D012306:Risk; D019851:Thrombophilia / Q000235:genetics*
D006710:Homocysteine; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate